A detailed history of Janus Henderson Group PLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 21,600 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,600
Previous 21,600 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
N/A
-213 Reduced 0.98%
21,600 $0
Q1 2024

May 15, 2024

BUY
N/A
4 Added 0.02%
21,813 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-74 Reduced 0.34%
21,809 $0
Q3 2023

Nov 14, 2023

BUY
N/A
4 Added 0.02%
21,883 $0
Q2 2023

Aug 14, 2023

BUY
N/A
21,879 New
21,879 $0

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.